Photo of David Magnusson

Lokon Pharma's Pipeline

Lokon Pharma focuses on the development of LOAd therapy for different types of cancer and in combination with other cancer therapeutics including chemotherapy and checkpoint blockade antibody therapy. The LOAd family includes a range of novel oncolytic viruses that are currently being evaluated for mechanisms-of-action (MOA) and proof-of-concept (POC).